Catalyst Wire Dossier Catalyst Wire Dossier

Tanzeum (albiglutide)

albiglutide · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tanzeum (albiglutide), covering 2014-07-01 to 2014-07-01. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 Diabetes [Phase 3]

See pricing